WASHINGTON (AP) - The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant.
Regulators approved HeartWare's Ventricular Assist System, a battery-powered device that is implanted in the chest, where it helps the heart's lower left chamber pump blood throughout the body.
The FDA has previously approved similar devices, known as ventricular assist devices, but HeartWare's device is smaller and may be easier to implant in some patients.
FDA says the approval was based on a company study of 137 advanced heart failure patients implanted with the device. Study results showed rates of adverse events, including infection and stroke, were similar to those seen with older devices.
Medical device maker HeartWare International Inc. is based in Framingham, Mass.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
BREAKING // The University of Texas Board of Regents adjourned Thursday without taking action on the job status of embattled UT President Bill Powers.
Longhorns coach Mack Brown talked with reporters Thursday for the first time since reports surfaced this week that he could be stepping down.
Google brings its new wearable computer to Austin this from Saturday, Dec.14 to Sunday, Dec. 15.
Despite what seemed like a surge of controversies, the Austin Aquarium opened its doors to members Thursday for a private pre-entry showing.
Austin police are still looking for a teen wanted on murder charges in the 2011 stabbing death of a 13-year-old boy.
A North Texas juvenile court judge has sentenced a 16-year-old boy to probation for a drunken-driving crash that killed four people near Fort Worth last summer.